Inflammatory bowel disease therapies and gut function in a colitis mouse model.

Background. Exclusive enteral nutrition (EEN) is a well-established approach to the management of Crohn's disease. Aim. To determine effects of EEN upon inflammation and gut barrier function in a colitis mouse model. Methods. Interleukin-10-deficient mice were inoculated with Helicobacter trogontum...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2013; pp. 909613 - 909614
Autores principales: Nahidi, Lily, Leach, Steven T, Mitchell, Hazel M, Kaakoush, Nadeem O, Lemberg, Daniel A, Munday, John S, Huinao, Karina, Day, Andrew S
Formato: Journal Article
Publicado: Wiley-Blackwell 2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104094730&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104094730
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 2013
      vid: 2013
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        104094730
        2012259412
        NLM24027765
        PMC3763566
        104094730
      ppf: 909613
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Inflammatory bowel disease therapies and gut function in a colitis mouse model.
      aug:
        au:
          Nahidi, Lily
          Leach, Steven T
          Mitchell, Hazel M
          Kaakoush, Nadeem O
          Lemberg, Daniel A
          Munday, John S
          Huinao, Karina
          Day, Andrew S
        affil: School of Women's and Children's Health, University of New South Wales, Randwick, Sydney, NSW 2031, Australia.
      sug:
        subj:
          Colitis Pathology
          Crohn Disease Pathology
          Inflammatory Bowel Diseases Pathology
          Interleukins
          Animals
          Colitis Microbiology
          Colitis Therapy
          Crohn Disease Microbiology
          Crohn Disease Therapy
          Models, Biological
          Enteral Nutrition
          Helicobacter
          Inflammation Microbiology
          Inflammation Pathology
          Inflammatory Bowel Diseases Microbiology
          Inflammatory Bowel Diseases Therapy
          Interleukins Metabolism
          Intestinal Mucosa Drug Effects
          Intestinal Mucosa Metabolism
          Metronidazole Administration and Dosage
          Mice
          RNA Metabolism
      ab: Background. Exclusive enteral nutrition (EEN) is a well-established approach to the management of Crohn's disease. Aim. To determine effects of EEN upon inflammation and gut barrier function in a colitis mouse model. Methods. Interleukin-10-deficient mice were inoculated with Helicobacter trogontum and then treated with EEN, metronidazole, hydrocortisone, or EEN and metronidazole combination. Blood and tissue were collected at 2 and 4 weeks with histology, mucosal integrity, tight junction integrity, inflammation, and H. trogontum load evaluated. Results. H. trogontum induced colitis in IL-10-/- mice with histological changes in the cecum and colon. Elevated mucosal IL-8 mRNA in infected mice was associated with intestinal barrier dysfunction indicated by decreased transepithelial electrical resistance and mRNA of tight junction proteins and increased short-circuit current, myosin light chain kinase mRNA, paracellular permeability, and tumor necrosis factor-a and myeloperoxidase plasma levels (P < 0.01 for all comparisons). EEN and metronidazole, but not hydrocortisone, treatments restored barrier function, maintained gut barrier integrity, and reversed inflammatory changes along with reduction of H. trogontum load (versus infected controls P < 0.05). Conclusion. H. trogontum infection in IL-10-/- mice induced typhlocolitis with intestinal barrier dysfunction. EEN and metronidazole, but not hydrocortisone, modulate barrier dysfunction and reversal of inflammatory changes.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N